| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/26/2009 | US20090054605 including a head assembly having an array of nozzles each coupled to a reservoir of liquid reagent and a base assembly having an array of reaction wells |
| 02/26/2009 | US20090054560 Method for preparing solid materials comprising immobilized proteorhodopsin |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054366 RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY |
| 02/26/2009 | US20090054362 Compounds |
| 02/26/2009 | US20090054361 Pot1 alternative splicing variants |
| 02/26/2009 | US20090054342 Bioactive peptides and method of using same |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054325 Compositions and methods for suppressing axonal growth inhibition |
| 02/26/2009 | US20090054322 Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions |
| 02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
| 02/26/2009 | US20090054253 Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using 66 Gene Panel |
| 02/26/2009 | US20090054250 Methods to create fluorescent biosensors using aptamers with fluorescent base analogs |
| 02/26/2009 | US20090054248 Connexin 40 tissue specific gene mutations |
| 02/26/2009 | US20090054247 Polynucleotides encoding proteins involved in plant metabolism |
| 02/26/2009 | US20090054246 Virus-like platform for rapid vaccine discovery |
| 02/26/2009 | US20090054244 Nucleic acid molecule encoding a novel estrogen receptor beta variant |
| 02/26/2009 | US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers |
| 02/26/2009 | US20090053821 Fluorescence quenching azo dyes, their methods of preparation and use |
| 02/26/2009 | US20090053794 improving production of amino acids, in particular L-lysine, L-tryptophan, L-proline, L-valine, L-isoleucine and L-homoserine; fermenting an isolated coryneform bacterium harboring a nucleic acid encoding an amino acid sequence comprising a a polypeptide having GTP-pyrophosphate kinase enzyme activity |
| 02/26/2009 | US20090053790 Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell |
| 02/26/2009 | US20090053768 Novel Phospholipase C Enzyme (S) |
| 02/26/2009 | US20090053764 Salutaridinol 7-0-Acetyltransferase and Derivatives Thereof |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053748 Cytochrome c protein and assay |
| 02/26/2009 | US20090053723 Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS) |
| 02/26/2009 | US20090053717 Methods and compositions for detecting spermatozoa or semen in a sample |
| 02/26/2009 | US20090053710 Functional molecule, functional molecule synthesizing amidite and target substance analysis method |
| 02/26/2009 | US20090053706 Dna methylation markers associated with the cpg island methylator phenotype (cimp) in human colorectal cancer |
| 02/26/2009 | US20090053704 Stabilization of nucleic acids on solid supports |
| 02/26/2009 | US20090053701 Detectable nucleic acid tag |
| 02/26/2009 | US20090053700 Optical sorting method |
| 02/26/2009 | US20090053698 Method for obtaining subtraction polynucleotide |
| 02/26/2009 | US20090053695 Gene Marker and Use Thereof |
| 02/26/2009 | US20090053687 Method for the detection of hpv and probes, primers and kits |
| 02/26/2009 | US20090053360 Gene encoding glycogen synthase and use thereof |
| 02/26/2009 | US20090053359 Ammonia transporter gene and use thereof |
| 02/26/2009 | US20090053311 Pharmaceutical Compositions for Treating or Preventing Bone Conditions |
| 02/26/2009 | US20090053298 constitutive active/androstane receptor (CAR); antisense agents; drug screening; hepatocytes |
| 02/26/2009 | US20090053265 Antigenic peptides and their use |
| 02/26/2009 | US20090053260 Algae essence nucleic acid fluid concentration preparation method |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | US20090053249 Specific Inhibition of Autoimmunity and Diseases Associated With Autoantigens |
| 02/26/2009 | US20090053237 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/26/2009 | US20090053233 Cytotoxic Antibody Directed Against Type B Lymphoid Hematopoietic Proliferations |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics |
| 02/26/2009 | US20090053213 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/26/2009 | US20090053212 Humanized anti-human osteopontin antibody |
| 02/26/2009 | US20090053210 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 02/26/2009 | US20090053206 Novel synthetic agonists of tlr9 |
| 02/26/2009 | US20090053205 Stabilized immune modulatory rna (simra) compounds |
| 02/26/2009 | US20090053203 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, obesity, cardiovascular, metabolic, neurodegenerative, gastrointestinal, autoimmune, rheumatological and infectious diseases; drug delivery |
| 02/26/2009 | US20090053201 Using variation in DNA polymerase sequence as diagnostic indicator of adefovir or tenofovir resistance in virus; viricides |
| 02/26/2009 | US20090053191 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 02/26/2009 | US20090053185 Coagulation factor x polypeptides with modified activation properties |
| 02/26/2009 | US20090053173 Stabilization of such as human interleukin 11; reduced toxicity; cost effective; shelf life; SARS virus, HIV, HCV, HBV, or HAV, and the cancer diseases, such as leukemia and malignant melanoma; between a human serum albumin and an Interferon |
| 02/26/2009 | US20090053148 Toll like receptor modulators |
| 02/26/2009 | US20090053147 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 02/26/2009 | US20090053145 Anti-viral compositions and methods of use in cattle |
| 02/26/2009 | US20090053138 Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology Therapeutics |
| 02/26/2009 | DE102005011003B9 Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren Method and means for the differential diagnosis of thyroid tumors |
| 02/26/2009 | CA2697055A1 Methods and compositions for post-transcriptional gene silencing |
| 02/26/2009 | CA2696363A1 Method for purifying or detecting a target protein |
| 02/25/2009 | EP2028278A1 RNA sequence-specific mediators of RNA interference |
| 02/25/2009 | EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene |
| 02/25/2009 | EP2026843A2 Therapeutic uses of inhibitors of rtp801l |
| 02/25/2009 | EP2026837A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 02/25/2009 | EP2026825A2 Furanone-initiated polymers |
| 02/25/2009 | EP1831401A4 Methods, compositions, and kits for forming self-complementary polynucleotides |
| 02/25/2009 | EP1828220A4 Methods and compositions for high sensitivity fluorescent mutation detection with mismatch cutting dna endonucleases |
| 02/25/2009 | EP1345495B1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/25/2009 | EP0906448B1 Methods for the diagnosis and prognosis of cancer |
| 02/25/2009 | CN101374958A Detection of ruminant DNA via PCR |
| 02/25/2009 | CN101374948A Variant humicola grisea CBH1.1 |
| 02/25/2009 | CN101374853A Methods and compositions for cancer therapy using a novel adenovirus |
| 02/25/2009 | CN101374852A Novel bacillus mHKcel cellulase |
| 02/25/2009 | CN101374851A Oligonucleotide synthesis using photocleavable linkers |
| 02/25/2009 | CN101374536A Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 02/25/2009 | CN100463962C Phenotypic screen of chimeric proteins |
| 02/24/2009 | US7495152 Identification and characterization of a novel alpha-amylase from maize endosperm |
| 02/24/2009 | US7495149 Comprises nucleotide sequences coding desaturases for transformation and propagation in plants; for generation of plants with minimum possible saturated fatty acids in seeds; enhanced dietary sources; tissue engineering |
| 02/24/2009 | US7495095 useful in obtaining an oligonucleic acid capable of recognizing a specific base and transferring a nitrosyl group in a sequence-specific manner; sequence specific mutagenesis |
| 02/24/2009 | US7495094 Amplification using oligonucleotide primers |
| 02/24/2009 | US7495093 Amplification and detection method |
| 02/24/2009 | US7495092 Compositions comprising promoter sequences and methods of use |
| 02/24/2009 | US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/24/2009 | US7495089 Inhibit endothelial cell proliferation, angiogenesis and cause tumor regression; antiproliferative, anticarcinogenic and antitumor agents |
| 02/24/2009 | US7495088 Nuclease resistant nucleotide capable of hybridizing with complementary RNA in a manner which inhibits function of the RNA |
| 02/24/2009 | US7495082 Antibodies to PRO4349 polypeptides |
| 02/24/2009 | US7495070 Avian pancreatic polypeptide comprising antigenic specificity for use in treatment and prevention of allergies, infection, inflammation, autoimmune and tumor disorders |
| 02/24/2009 | US7494982 Modified oligonucleotides for telomerase inhibition |
| 02/24/2009 | US7494981 Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors |
| 02/24/2009 | US7494817 Mixing cellular debris and magnetically-responsive particles (having glass microfiber coating) to facilitate reversible immobilization of genomic nucleic acid; bioassay |
| 02/24/2009 | US7494810 Method for accessing microbial diversity |
| 02/24/2009 | US7494805 Expression cassette and vector for transient or stable expression of exogenous molecules |
| 02/24/2009 | US7494801 Method of selecting Escherichia coli strain which highly expresses exogenous genes, Escherichia coli mutant strains selected by this method and process for producing enzymes and compounds using the same |
| 02/24/2009 | US7494796 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells |
| 02/24/2009 | US7494793 21686, dehydrogenase |
| 02/24/2009 | US7494786 Genetically engineered nuclear inclusion proteinase (NIa) comprising increased stability for obtaining large quantities of purified active proteins that form inclusion bodies in cells; modifying enzyme for premature polypeptides |